Grant Number:	1R01CA136950-01A1 Interpret this number
Primary Investigator:	Cho, Eunyoung
Organization:	Brigham And Women'S Hospital
Project Title:	Dietary Methyl Score, Genomic DNA Methylation and Colorectal Cancer
Fiscal Year:	2009

DESCRIPTION (provided by applicant): One-carbon metabolism is a critical pathway in cancer epigenetics because it directs the methylation of DNA and RNA and is involved in DNA synthesis and repair. There is no good systemic marker of one-carbon metabolism status. Abnormal one-carbon metabolism may lead to genomic (global) hypomethylation in systemic blood DNA, which may predispose the development of neoplasia; if so, genomic methylation status in blood DNA may serve as a good systemic marker of one-carbon metabolism status. Several dietary factors including folate, alcohol, methionine, riboflavin, vitamins B6 and B12, choline, and betaine mediate or facilitate one-carbon metabolism pathway. We currently do not know the optimum balance of these multiple dietary factors to achieve maximum function in the pathway and to minimize cancer risk. Therefore, we propose to evaluate pre-diagnostic genomic methylation of leukocyte DNA in relation to colorectal cancer risk in large prospective studies and expect that individuals with reduced levels of genomic DNA methylation are at increased risk of colorectal cancer. We also propose to elucidate the associations between major plasma components of one-carbon metabolism (total folate, unmetabolized folic acid, 5-methyl-tetrahydrofolate, vitamins B6 and B12, cysteine, homocysteine, and methylene-tetrahydrofolate reductase gene) and genomic DNA methylation, to determine the role of each component in genomic DNA methylation and further validate the biological relevance of genomic methylation assessment in blood DNA. We finally propose to identify dietary predictors of genomic DNA hypomethylation, create a 'dietary methyl score', and examine the score in relation to colorectal adenoma/cancer risks. We hypothesize that the 'dietary methyl score' predicts risks of colorectal adenoma/cancer more strongly than the individual dietary predictors. We will also evaluate 'dietary methyl score' in relation to several molecular and epigenetic subtypes of colorectal cancer including tumors with LINE-1 hypomethylation, CpG island methylator phenotype (CIMP)-high, or microsatellite instability (MSI)- high. This application will take advantage of two large ongoing prospective follow-up studies of women and men with 666/1332 colorectal cancer cases/controls with pre-diagnostic blood samples for genomic methylation status of leukocyte DNA. We also expect to include 6,025 colorectal adenoma and 2,794 colorectal cancer cases to evaluate the relationships with 'dietary methyl score'. With several previously assessed plasma components of one-carbon metabolism and molecular subtypes of colorectal tumor, we are uniquely positioned to address these issues in an extremely time- and cost-effective manner. Our work will elucidate a new insight into how dietary factors and one-carbon metabolism affects the epigenetics of cancer in humans. Genomic methylation in leukocyte DNA can potentially serve as a diagnostic tool or target for cancer prevention because it is potentially modifiable. Dietary methyl score will help produce practical dietary guidelines for cancer prevention. PUBLIC HEALTH RELEVANCE: Our study will evaluate the biological relevance of pre-diagnostic genomic methylation status of blood DNA as a measure of body's systemic methylation status and a predictor of cancer. The methylation status could be potentially utilized for early detection of cancer and a target for cancer prevention because it is potentially modifiable. Creation of 'dietary methyl score' will present the optimum balance of multiple dietary factors affecting one-carbon metabolism to reduce cancer risk and help produce practical dietary guidelines for cancer prevention.




Vitamin B2 intake and colorectal cancer risk; results from the Nurses' Health Study and the Health Professionals Follow-Up Study cohort.
Authors: Yoon Y.S. , Jung S. , Zhang X. , Ogino S. , Giovannucci E.L. , Cho E. .
Source: International Journal Of Cancer, 2016-09-01 00:00:00.0; 139(5), p. 996-1008.
PMID: 27081929
Related Citations

Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.
Authors: Inamura K. , Song M. , Jung S. , Nishihara R. , Yamauchi M. , Lochhead P. , Qian Z.R. , Kim S.A. , Mima K. , Sukawa Y. , et al. .
Source: Journal Of The National Cancer Institute, 2016 Apr; 108(4), .
PMID: 26598515
Related Citations

Unmetabolized Folic Acid in Prediagnostic Plasma and the Risk of Colorectal Cancer.
Authors: Cho E. , Zhang X. , Townsend M.K. , Selhub J. , Paul L. , Rosner B. , Fuchs C.S. , Willett W.C. , Giovannucci E.L. .
Source: Journal Of The National Cancer Institute, 2015 Dec; 107(12), p. djv260.
PMID: 26376686
Related Citations

Derivation and validation of homocysteine score in u.s. Men and women.
Authors: Jung S. , Je Y. , Giovannucci E.L. , Rosner B. , Ogino S. , Cho E. .
Source: The Journal Of Nutrition, 2015 Jan; 145(1), p. 96-104.
PMID: 25527664
Related Citations

Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.
Authors: Inamura K. , Yamauchi M. , Nishihara R. , Lochhead P. , Qian Z.R. , Kuchiba A. , Kim S.A. , Mima K. , Sukawa Y. , Jung S. , et al. .
Source: Journal Of The National Cancer Institute, 2014 Sep; 106(9), .
PMID: 25190725
Related Citations

Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression.
Authors: Jung S. , Qian Z.R. , Yamauchi M. , Bertrand K.A. , Fitzgerald K.C. , Inamura K. , Kim S.A. , Mima K. , Sukawa Y. , Zhang X. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2014 Aug; 23(8), p. 1628-37.
PMID: 24920642
Related Citations

Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).
Authors: Fink S.P. , Yamauchi M. , Nishihara R. , Jung S. , Kuchiba A. , Wu K. , Cho E. , Giovannucci E. , Fuchs C.S. , Ogino S. , et al. .
Source: Science Translational Medicine, 2014-04-23 00:00:00.0; 6(233), p. 233re2.
PMID: 24760190
Related Citations

Total calcium intake and colorectal adenoma in young women.
Authors: Massa J. , Cho E. , Orav E.J. , Willett W.C. , Wu K. , Giovannucci E.L. .
Source: Cancer Causes & Control : Ccc, 2014 Apr; 25(4), p. 451-60.
PMID: 24562904
Related Citations

No association between garlic intake and risk of colorectal cancer.
Authors: Meng S. , Zhang X. , Giovannucci E.L. , Ma J. , Fuchs C.S. , Cho E. .
Source: Cancer Epidemiology, 2013 Apr; 37(2), p. 152-5.
PMID: 23265869
Related Citations

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.
Authors: Ogino S. , Lochhead P. , Chan A.T. , Nishihara R. , Cho E. , Wolpin B.M. , Meyerhardt J.A. , Meissner A. , Schernhammer E.S. , Fuchs C.S. , et al. .
Source: Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc, 2013 Apr; 26(4), p. 465-84.
PMID: 23307060
Related Citations

Pre-diagnostic leukocyte genomic DNA methylation and the risk of colorectal cancer in women.
Authors: Nan H. , Giovannucci E.L. , Wu K. , Selhub J. , Paul L. , Rosner B. , Fuchs C.S. , Cho E. .
Source: Plos One, 2013; 8(4), p. e59455.
PMID: 23560049
Related Citations